← Back to Discover
Qiming U.S. Ventures Management, LLC
Period ended Sep 30, 2025 · Latest filing Nov 10, 2025
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2025: $55,636,803
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2025. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- TOURMALINE BIO INC · COM · 89157D105 · shares: $35,475,081
- KORRO BIO INC · COM · 500946108 · shares: $17,627,591
- JASPER THERAPEUTICS INC · COM NEW · 471871202 · shares: $2,210,934
- KEZAR LIFE SCIENCES INC · COM NEW · 49372L209 · shares: $323,197
Reported holdings
4 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| TOURMALINE BIO INC | COM | 89157D105 | — | 741,691 shares | $35,475,081 |
| KORRO BIO INC | COM | 500946108 | — | 368,085 shares | $17,627,591 |
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | — | 928,964 shares | $2,210,934 |
| KEZAR LIFE SCIENCES INC | COM NEW | 49372L209 | — | 82,871 shares | $323,197 |